Helsinki, Finland

Ville Miettinen

USPTO Granted Patents = 17 

 

Average Co-Inventor Count = 2.5

ph-index = 2

Forward Citations = 14(Granted Patents)


Company Filing History:


Years Active: 2018-2025

Loading Chart...
Loading Chart...
17 patents (USPTO):Explore Patents

Title: Ville Miettinen: Innovator in Eye-Tracking Technology

Introduction

Ville Miettinen is a prominent inventor based in Helsinki, Finland. He has made significant contributions to the field of eye-tracking technology, holding a total of 17 patents. His innovative work focuses on enhancing user experience through advanced visual technologies.

Latest Patents

Among his latest patents is the "Gaze-assisted stereo reprojection." This invention involves rendering parts of left and right images based on the user's gaze point, allowing for a more immersive visual experience. The left part of the left image and the right part of the right image are rendered with specific horizontal fields of view extending towards the gaze point. Additionally, he has developed an "Eyeglass lens with eye-tracking components." This apparatus includes light sources and sensors arranged around the lens to track the user's eye movements, providing valuable data on gaze direction.

Career Highlights

Ville Miettinen has worked with notable companies such as Varjo Technologies and Pixieray. His experience in these organizations has allowed him to refine his skills and contribute to cutting-edge projects in the field of eye-tracking and visual technology.

Collaborations

Throughout his career, Miettinen has collaborated with talented individuals, including Mikko Strandborg and Klaus Melakari. These partnerships have fostered innovation and creativity in his projects.

Conclusion

Ville Miettinen's work in eye-tracking technology exemplifies the impact of innovative thinking in enhancing user experiences. His patents and career achievements highlight his dedication to advancing this exciting field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…